Nathan Treybeck
Stock Analyst at Wells Fargo
(2.02)
# 3,387
Out of 5,140 analysts
22
Total ratings
46.67%
Success rate
7.01%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Nathan Treybeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRTC iRhythm Holdings | Maintains: Overweight | $220 → $225 | $163.65 | +37.49% | 6 | Jan 13, 2026 | |
| LMAT LeMaitre Vascular | Maintains: Equal-Weight | $97 → $93 | $86.99 | +6.91% | 2 | Nov 7, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Overweight | $58 → $51 | $30.95 | +64.78% | 9 | Nov 5, 2025 | |
| ITGR Integer Holdings | Downgrades: Equal-Weight | $132 → $80 | $87.00 | -8.05% | 4 | Oct 24, 2025 | |
| RMD ResMed | Initiates: Equal-Weight | $280 | $259.28 | +7.99% | 1 | Oct 13, 2025 |
iRhythm Holdings
Jan 13, 2026
Maintains: Overweight
Price Target: $220 → $225
Current: $163.65
Upside: +37.49%
LeMaitre Vascular
Nov 7, 2025
Maintains: Equal-Weight
Price Target: $97 → $93
Current: $86.99
Upside: +6.91%
PROCEPT BioRobotics
Nov 5, 2025
Maintains: Overweight
Price Target: $58 → $51
Current: $30.95
Upside: +64.78%
Integer Holdings
Oct 24, 2025
Downgrades: Equal-Weight
Price Target: $132 → $80
Current: $87.00
Upside: -8.05%
ResMed
Oct 13, 2025
Initiates: Equal-Weight
Price Target: $280
Current: $259.28
Upside: +7.99%